Promimic
10.90 SEK
-7.63 %
Less than 1K followers
PRO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Promimic
P/B
Median 2022-2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share price (SEK) | 11.60 | 32.70 | 22.50 | 16.95 |
| Shares | 18.4 | 18.7 | 18.9 | 18.9 |
| Market cap | 213.7 | 610.1 | 425.9 | 320.2 |
| Enterprise value | - | - | - | - |
| EV/S | - | - | - | - |
| EV/EBITDA | - | - | - | - |
| EV/EBIT | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. |
| P/B | 2.63 | 7.95 | 6.09 | 5.42 |
| P/S | 13.2 | 16.5 | 9.7 | 7.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 87.7 % | 82.6 % | 79.4 % | 78.1 % |
| Gearing ratio | - | - | - | - |